Anna B. Morris

604 total citations
19 papers, 337 citations indexed

About

Anna B. Morris is a scholar working on Immunology, Transplantation and Surgery. According to data from OpenAlex, Anna B. Morris has authored 19 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 5 papers in Transplantation and 4 papers in Surgery. Recurrent topics in Anna B. Morris's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (9 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Anna B. Morris is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (9 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Anna B. Morris collaborates with scholars based in United States, Canada and United Kingdom. Anna B. Morris's co-authors include Mandy L. Ford, Clara R. Farley, David F. Pinelli, Christopher T. Petersen, Sunil S. Raikar, Edmund K. Waller, H. Trent Spencer, Christopher R. Flowers, Ashley D. Staton and Howard M. Gebel and has published in prestigious journals such as Blood, Immunity and Frontiers in Immunology.

In The Last Decade

Anna B. Morris

14 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna B. Morris United States	10	175	138	76	61	49	19	337
L.A. Smyth United Kingdom	9	332 1.9×	165 1.2×	97 1.3×	64 1.0×	58 1.2×	13	489
Gavin Whitehouse United Kingdom	7	191 1.1×	66 0.5×	129 1.7×	74 1.2×	53 1.1×	12	436
Betty Joe Canada	9	243 1.4×	132 1.0×	55 0.7×	31 0.5×	72 1.5×	22	364
Kai Sontheimer Germany	6	537 3.1×	184 1.3×	75 1.0×	30 0.5×	22 0.4×	7	653
Isabela Schmitt‐Knosalla Germany	6	409 2.3×	65 0.5×	40 0.5×	50 0.8×	79 1.6×	7	525
Romy E. Hoeppli Canada	10	588 3.4×	352 2.6×	100 1.3×	73 1.2×	67 1.4×	17	786
Nicholas A.J. Dawson Canada	6	291 1.7×	169 1.2×	46 0.6×	24 0.4×	42 0.9×	7	407
Laetitia Gautreau‐Rolland France	11	214 1.2×	64 0.5×	127 1.7×	9 0.1×	74 1.5×	21	412
Sarada L. Nandiwada United States	9	411 2.3×	123 0.9×	67 0.9×	14 0.2×	37 0.8×	13	522
Linghui Xia China	11	99 0.6×	209 1.5×	82 1.1×	23 0.4×	20 0.4×	26	455

Countries citing papers authored by Anna B. Morris

Since Specialization

Citations

This map shows the geographic impact of Anna B. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna B. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna B. Morris more than expected).

Fields of papers citing papers by Anna B. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna B. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna B. Morris. The network helps show where Anna B. Morris may publish in the future.

Co-authorship network of co-authors of Anna B. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Anna B. Morris. A scholar is included among the top collaborators of Anna B. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna B. Morris. Anna B. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Foster, P. S., Maria A. Cardenas, Anna B. Morris, et al.. (2025). Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction. Immunity. 58(2). 448–464.e6. 2 indexed citations

Morris, Anna B., Max W. Adelman, Michael H. Woodworth, et al.. (2025). Fgl2 regulates FcγRIIB+CD8+ T cell responses during infection. JCI Insight. 10(7).

Magua, Wairimu, Anna B. Morris, Alexis K. Okoh, et al.. (2025). Belatacept-based immunosuppression in heart transplant recipients: A single center experience. JHLT Open. 9. 100277–100277.

Morris, Anna B., et al.. (2024). Hiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups. Human Immunology. 85(6). 111115–111115.

Morris, Anna B., Kristina Ortiz, G. Tong Zhou, et al.. (2024). Major histocompatibility complex and peptide specificity underpin CD8+ T cell direct alloresponse. American Journal of Transplantation. 25(5). 916–929. 2 indexed citations

Roback, John D., et al.. (2024). Mitigating the Prozone‐Like Effect in HLA Antibody Testing: A Case Report of Therapeutic Plasma Exchange for Antibody‐Mediated Rejection Post‐Heart Transplantation. Journal of Clinical Apheresis. 39(5). e22144–e22144.

Lefaucheur, Carmen, Kévin Louis, Anna B. Morris, et al.. (2023). Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document. American Journal of Transplantation. 23(1). 115–132. 38 indexed citations

Morris, Anna B., et al.. (2022). A Primer on Chimerism Analysis: A Straightforward, Thorough Review. Laboratory Medicine. 54(4). 352–362.

Farley, Clara R., et al.. (2021). FcγRIIB is a T cell checkpoint in antitumor immunity. JCI Insight. 6(4). 25 indexed citations

10.

Zhang, Weiwen, et al.. (2021). CMV Status Drives Distinct Trajectories of CD4+ T Cell Differentiation. Frontiers in Immunology. 12. 620386–620386. 20 indexed citations

11.

Morris, Anna B., Clara R. Farley, David F. Pinelli, et al.. (2020). Signaling through the Inhibitory Fc Receptor FcγRIIB Induces CD8+ T Cell Apoptosis to Limit T Cell Immunity. Immunity. 52(1). 136–150.e6. 71 indexed citations

12.

Krummey, Scott M., Anna B. Morris, Jesica R. Jacobs, et al.. (2020). CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence. Cell Reports. 30(5). 1282–1291.e5. 15 indexed citations

13.

Morris, Anna B., David F. Pinelli, Danya Liu, Maylene E. Wagener, & Mandy L. Ford. (2020). Memory T cell–mediated rejection is mitigated by FcγRIIB expression on CD8+ T cells. American Journal of Transplantation. 20(8). 2206–2215. 11 indexed citations

14.

Morris, Anna B. & Mandy L. Ford. (2019). When rubber meets the road: how innate features of adaptive immune cells play critical roles in transplant alloimmunity. Current Opinion in Organ Transplantation. 24(6). 659–663. 2 indexed citations

15.

Morris, Anna B., Harold C. Sullivan, Scott M. Krummey, Howard M. Gebel, & Robert A. Bray. (2019). Out with the old, in with the new: Virtual versus physical crossmatching in the modern era. HLA. 94(6). 471–481. 24 indexed citations

16.

Morris, Anna B., et al.. (2018). Influence of T Cell Coinhibitory Molecules on CD8+ Recall Responses. Frontiers in Immunology. 9. 1810–1810. 18 indexed citations

17.

Petersen, Christopher T., Anna B. Morris, Ashley D. Staton, et al.. (2018). Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists. Blood Advances. 2(3). 210–223. 87 indexed citations

18.

Waller, Edmund K., Anna B. Morris, Ashley D. Staton, et al.. (2017). Optimization of Ex Vivo Activation and Expansion of T Cells for Therapy of Lymphoma Via Antagonism of PI3K δ and Vasoactive Intestinal Peptide Signaling. Blood. 130. 3195–3195. 1 indexed citations

19.

Martinez, Ryan J., et al.. (2016). Targeted loss of SHP1 in murine thymocytes dampens TCR signaling late in selection. European Journal of Immunology. 46(9). 2103–2110. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact